Integral Diagnostics Ltd
ASX:IDX
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.66
3.17
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Integral Diagnostics Ltd
Integral Diagnostics Ltd
Net Issuance of Common Stock
Integral Diagnostics Ltd
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Integral Diagnostics Ltd
ASX:IDX
|
Net Issuance of Common Stock
AU$1.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Healthia Ltd
ASX:HLA
|
Net Issuance of Common Stock
AU$13.4m
|
CAGR 3-Years
151%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sonic Healthcare Ltd
ASX:SHL
|
Net Issuance of Common Stock
AU$194.4m
|
CAGR 3-Years
54%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
18%
|
|
|
Capitol Health Ltd
ASX:CAJ
|
Net Issuance of Common Stock
AU$518k
|
CAGR 3-Years
10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Australian Clinical Labs Ltd
ASX:ACL
|
Net Issuance of Common Stock
-AU$1.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
Healius Ltd
ASX:HLS
|
Net Issuance of Common Stock
AU$179.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Integral Diagnostics Ltd
Glance View
Integral Diagnostics Ltd. engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied professionals. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-10-21. The firm is principally engaged in providing medical imaging services to patients and their referrers across Australia and New Zealand. The firm offers its services through its three brands in Australian states, which include Lake Imaging in Victoria, South Coast Radiology and Imaging Queensland in Queensland and Apex Radiology in Western Australia. IDX also operates in New Zealand through the Ascot Radiology, SRG Radiology and Trinity MRI brands. The firm has approximately 72 radiology clinics, including 26 comprehensive sites. IDX offers its services through its subsidiaries.
See Also
What is Integral Diagnostics Ltd's Net Issuance of Common Stock?
Net Issuance of Common Stock
1.7m
AUD
Based on the financial report for Jun 30, 2024, Integral Diagnostics Ltd's Net Issuance of Common Stock amounts to 1.7m AUD.
What is Integral Diagnostics Ltd's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
2%
Over the last year, the Net Issuance of Common Stock growth was -22%. The average annual Net Issuance of Common Stock growth rates for Integral Diagnostics Ltd have been -1% over the past three years , 2% over the past five years .
You don't have any saved screeners yet
